Awardee OrganizationSALK INSTITUTE FOR BIOLOGICAL STUDIES
Description
Abstract Text
Project Summary/Abstract
Our overall goal is to gain a better understanding of mechanisms underlying the DNA damage response (DDR)
and maintenance of genomic integrity. We will study the function of the CtIP tumor suppressor protein,
conserved in all eukaryotes. Specifically, we will investigate the role of CtIP in DNA double-strand break (DSB)
end processing, and ATR activation, and its function in the process of 5'->3' resection at a DSB. Our
preliminary studies in the Xenopus egg extract indicate that CtIP acts downstream of ATM in response to
DSBs, and promotes DSB 5' end resection to generate ssDNA, triggering ATR and checkpoint activation. We
will use the Xenopus extract and human cell lines, coupled with biochemical studies, to gain mechanistic
understanding of the checkpoint role of CtIP and the process of DSB 5' end resection. In particular, we will ask
if CtIP is important for processing DSBs with blocked ends, and if CtIP has intrinsic nuclease activity required
for 5'->3' resection. We will determine the functional relationships between CtIP, ATM and the Mre11-Rad50-
Nbs1 complex in resection. We have discovered a conserved class of RING finger E3 ubiquitin ligases that
specifically target SUMOylated proteins. RNF4 family proteins (S. pombe Rfp1/Rfp2-Slx8, or human RNF4)
recognize SUMOylated proteins via an N-terminal SUMO-interacting motif (SIM), and ubiquitinate SUMOylated
proteins in vitro, dependent on the SIM and RING domains. RNF4 orthologues are implicated in maintenance
of genomic integrity in several organisms. To elucidate the physiological roles of RNF4 family proteins, we will
identify in vivo targets for RNF4 family proteins using GST-SIM and tagged-SUMO to affinity purify
SUMOylated proteins from yeast and human cells, followed by validation and functional characterization of
identified proteins as RNF4 targets in vivo and in vitro. We will test candidate proteins implicated by genetic
interactions with Rfp1/2 in S. pombe and through physical interaction with RNF4 as targets, including TRIM
family proteins. We will determine the significance of the unique structural elements in the multi-SIM and RING
domains of RNF4 family proteins in target recognition, and test the model that they recognize poly-
SUMOylated proteins. Overall, we expect to learn how RNF4 family proteins function in the DNA damage
response and in maintaining genomic integrity. The DNA damage response pathway involves activation of a
series of protein kinases, including ATM, ATR, and Chk1/Chk2. To learn more about the network of events
downstream of DNA damage, we will use SILAC labeling, phosphoprotein/peptide enrichment, and quantitative
mass spectrometry to identify and functionally characterize novel protein phosphorylation sites in mammalian
cells induced by DNA damage. For this purpose, we will use a synchronized HeLa cell system where DNA
damage is induced with MMS; samples taken at various times and doses of MMS will be analyzed by mass
spectrometry for novel phosphorylation events, whose role in the DDR will subsequently be determined.
Public Health Relevance Statement
Public Health Relevance
The studies proposed in this application seek to elucidate at the molecular level how cells respond to DNA
damage and maintain a stable genome, which are key to understanding how cells safeguard against the
development of cancer-causing mutations. Since many cancer therapeutics kill cancer cells by eliciting DNA
damage, our studies will also provide insights into the sensitivity of cancer cells to these agents, and
suggest ways to improve their use.
No Sub Projects information available for 5R01CA080100-14
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA080100-14
Patents
No Patents information available for 5R01CA080100-14
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA080100-14
Clinical Studies
No Clinical Studies information available for 5R01CA080100-14
News and More
Related News Releases
No news release information available for 5R01CA080100-14
History
No Historical information available for 5R01CA080100-14
Similar Projects
No Similar Projects information available for 5R01CA080100-14